Intervention

bupropion hydrochloride

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5

Recruiting0

Common conditions12

Lead sponsors shown5

Clinical trials

5 shown

Health Education Counseling With or Without Bupropion in Helping African Americans Stop SmokingNCT00666978 · 2007-12-01

COMPLETED

Bupropion in Helping Adults Stop SmokingNCT00534001 · 2006-01-01

COMPLETED

Study Of 323U66 SR In Major Depressive DisorderNCT00135512 · 2004-12-01

COMPLETED

Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of SmokingNCT00033592 · 2002-02-01

COMPLETED

S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone SurgeryNCT00032084 · 2002-01-01

TERMINATED

Common conditions

Lung Cancer4 Bladder Cancer2 Cervical Cancer2 Esophageal Cancer2 Gastric Cancer2 Head and Neck Cancer2 Kidney Cancer2 Leukemia2 Liver Cancer2 Pancreatic Cancer2 Tobacco Use Disorder2 Depressive Disorder1

Leading sponsors

Alliance for Clinical Trials in Oncology1 GlaxoSmithKline1 Lisa Sanderson Cox, PhD1 Roswell Park Cancer Institute1 SWOG Cancer Research Network1

Trial status mix

COMPLETED4

TERMINATED1

Phase mix

PHASE22

PHASE32

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.